• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素及其脑代谢产物 N(1)-乙酰-5-甲氧基色胺能预防帕金森病小鼠线粒体一氧化氮合酶的诱导。

Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.

机构信息

Centro de Investigación Biomédica, Instituto de Biotecnología, Universidad de Granada, Granada, Spain.

出版信息

J Neurosci Res. 2009 Oct;87(13):3002-10. doi: 10.1002/jnr.22123.

DOI:10.1002/jnr.22123
PMID:19437546
Abstract

Melatonin prevents mitochondrial failure in models of sepsis through its ability to inhibit the expression and activity of both cytosolic (iNOS) and mitochondrial (i-mtNOS) inducible nitric oxide synthases. Because Parkinson's disease (PD), like sepsis, is associated with iNOS induction, we assessed the existence of changes in iNOS/i-mtNOS and their relation with mitochondrial dysfunction in the MPTP model of PD, which also displays increased iNOS expression. We also evaluated the role of melatonin (aMT) and its brain metabolite, N(1)-acetyl-5-methoxykynuramine (AMK), in preventing i-mtNOS induction and mitochondrial failure in this model of PD. Mitochondria from substantia nigra (SN) and, to a lesser extent, from striatum (ST) showed a significant increase in i-mtNOS activity, nitrite levels, oxidative stress, and complex I inhibition after MPTP treatment. MPTP-induced i-mtNOS was probably related to mitochondrial failure, because its prevention by aMT and AMK reduced oxidative/nitrosative stress and restored complex I activity. These findings represent the first experimental evidence of a potential role for i-mtNOS in the mitochondrial failure of PD and support a novel mechanism in the neuroprotective effects of aMT and AMK.

摘要

褪黑素通过抑制细胞质(iNOS)和线粒体(i-mtNOS)诱导型一氧化氮合酶的表达和活性来防止脓毒症模型中的线粒体衰竭。由于帕金森病(PD)与 iNOS 诱导有关,我们评估了在 PD 的 MPTP 模型中 iNOS/i-mtNOS 的变化及其与线粒体功能障碍的关系,该模型也显示 iNOS 表达增加。我们还评估了褪黑素(aMT)及其脑代谢物 N(1)-乙酰-5-甲氧基色氨酸(AMK)在预防 PD 模型中 i-mtNOS 诱导和线粒体衰竭中的作用。MPTP 处理后,黑质(SN)和(程度较小)纹状体(ST)的线粒体中 i-mtNOS 活性、亚硝酸盐水平、氧化应激和复合物 I 抑制显著增加。MPTP 诱导的 i-mtNOS 可能与线粒体衰竭有关,因为 aMT 和 AMK 的预防可降低氧化/硝化应激并恢复复合物 I 活性。这些发现代表了 i-mtNOS 在 PD 线粒体衰竭中潜在作用的第一个实验证据,并支持 aMT 和 AMK 的神经保护作用的新机制。

相似文献

1
Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.褪黑素及其脑代谢产物 N(1)-乙酰-5-甲氧基色胺能预防帕金森病小鼠线粒体一氧化氮合酶的诱导。
J Neurosci Res. 2009 Oct;87(13):3002-10. doi: 10.1002/jnr.22123.
2
Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin.败血症小鼠膈肌线粒体中诱导型一氧化氮合酶的鉴定:其与线粒体功能障碍的关系及褪黑素的预防作用
Int J Biochem Cell Biol. 2006 Feb;38(2):267-78. doi: 10.1016/j.biocel.2005.09.008. Epub 2005 Sep 30.
3
Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice.褪黑素可对抗脓毒症小鼠骨骼肌中诱导型线粒体一氧化氮合酶依赖性的线粒体功能障碍。
J Pineal Res. 2006 Jan;40(1):71-8. doi: 10.1111/j.1600-079X.2005.00281.x.
4
Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.合成犬尿氨酸对小鼠 1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的帕金森病的保护作用。
Brain Res Bull. 2011 May 30;85(3-4):133-40. doi: 10.1016/j.brainresbull.2011.03.008. Epub 2011 Mar 17.
5
The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS.褪黑素对脓毒症中心肌线粒体损伤的有益作用:抑制 iNOS 和保护 nNOS。
J Pineal Res. 2014 Jan;56(1):71-81. doi: 10.1111/jpi.12099. Epub 2013 Oct 21.
6
Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice.褪黑素对脓毒症小鼠心脏线粒体功能障碍的减轻作用
FEBS J. 2007 Apr;274(8):2135-47. doi: 10.1111/j.1742-4658.2007.05755.x. Epub 2007 Mar 20.
7
Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.帕金森病小鼠的线粒体损伤及褪黑素保护作用不依赖于诱导型或神经元型一氧化氮合酶。
PLoS One. 2017 Aug 11;12(8):e0183090. doi: 10.1371/journal.pone.0183090. eCollection 2017.
8
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.褪黑素及其代谢产物N1-乙酰基-N2-甲酰基-5-甲氧基犬尿胺(AFMK)和N1-乙酰基-5-甲氧基犬尿胺(AMK)在巨噬细胞中的抗炎作用。
J Neuroimmunol. 2005 Aug;165(1-2):139-49. doi: 10.1016/j.jneuroim.2005.05.002.
9
In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state.左旋多巴给药后黑质中热休克蛋白的体内诱导与大鼠线粒体复合物I活性增加及亚硝化应激有关:受谷胱甘肽氧化还原状态调节
J Neurochem. 2007 May;101(3):709-17. doi: 10.1111/j.1471-4159.2006.04367.x. Epub 2007 Jan 4.
10
Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats.褪黑素可对抗脂多糖诱导的大鼠线粒体一氧化氮合酶的表达及活性。
FASEB J. 2003 May;17(8):932-4. doi: 10.1096/fj.02-0692fje. Epub 2003 Mar 28.

引用本文的文献

1
The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging.褪黑素及其代谢物在神经保护和延缓大脑衰老中的重要作用。
Int J Mol Sci. 2024 May 8;25(10):5122. doi: 10.3390/ijms25105122.
2
Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin.氧化应激和衰老作为阿尔茨海默病和帕金森病的风险因素:抗氧化剂褪黑素的作用。
Int J Mol Sci. 2023 Feb 3;24(3):3022. doi: 10.3390/ijms24033022.
3
Neuroprotective Effects of Some Nutraceuticals against Manganese-Induced Parkinson's Disease in Rats: Possible Modulatory Effects on TLR4/NLRP3/NF-κB, GSK-3β, Nrf2/HO-1, and Apoptotic Pathways.
某些营养保健品对锰诱导的大鼠帕金森病的神经保护作用:对TLR4/NLRP3/NF-κB、GSK-3β、Nrf2/HO-1和凋亡途径的可能调节作用
Pharmaceuticals (Basel). 2022 Dec 14;15(12):1554. doi: 10.3390/ph15121554.
4
Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson's Disease.用于治疗帕金森病的新型双NRF2诱导剂和选择性单胺氧化酶B抑制剂系列
Antioxidants (Basel). 2022 Jan 27;11(2):247. doi: 10.3390/antiox11020247.
5
Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions.褪黑素的氧化还原生物学:区分昼夜节律和非昼夜节律功能。
Antioxid Redox Signal. 2022 Oct;37(10-12):704-725. doi: 10.1089/ars.2021.0275. Epub 2022 Feb 10.
6
Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders.通过化学功能化增强褪黑素的益处:对多因素神经退行性疾病的可能影响。
Int J Mol Sci. 2021 Oct 27;22(21):11584. doi: 10.3390/ijms222111584.
7
Effect of Melatonin Administration on Mitochondrial Activity and Oxidative Stress Markers in Patients with Parkinson's Disease.褪黑素给药对帕金森病患者线粒体活性和氧化应激标志物的影响。
Oxid Med Cell Longev. 2021 Oct 18;2021:5577541. doi: 10.1155/2021/5577541. eCollection 2021.
8
Melatonin, Its Metabolites and Their Interference with Reactive Nitrogen Compounds.褪黑素、其代谢产物及其与活性氮化合物的相互干扰。
Molecules. 2021 Jul 5;26(13):4105. doi: 10.3390/molecules26134105.
9
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.褪黑素作为帕金森病中的一种时间生物学剂和细胞保护剂
Front Pharmacol. 2021 Apr 15;12:650597. doi: 10.3389/fphar.2021.650597. eCollection 2021.
10
Molecular Mechanisms of Melatonin-Mediated Cell Protection and Signaling in Health and Disease.褪黑素介导的细胞保护及健康与疾病中的信号传导分子机制
Pharmaceutics. 2021 Jan 20;13(2):129. doi: 10.3390/pharmaceutics13020129.